Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
Kennesaw State University · NCT06259799
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- April 1, 2024
- Record last updated
- September 2, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Approximately 60% of males and 40% of females do not meet current fluid intake recommendations, which is associated with adverse health consequences such as obesity, diabetes, and chronic kidney disease. Newer technologies have been designed to promote fluid intake. "Smart Water Bottles" use mHealth technology to capture fluid intake behaviors automatically and provide cues to encourage fluid consumption. Studies using Smart Water Bottles have helped some individuals increase fluid intake to help reduce kidney stone formation. However, limited research has assessed the efficacy of this technology on improving fluid intake in college students. College is a time with the potential to form healthy habits that carry into adulthood. Previous work has also identified daily changes in morning urine color, thirst perception, and body mass, as simple, inexpensive indicators of daily fluctuations in water balance. Tracking changes in these metrics has the potential to provide participants with evidence of adequate or inadequate fluid consumption. Thus, the combination of prompting from a smart water bottle, as well as daily self-monitoring changes in hydration status, may encourage college students to increase daily fluid consumption.
Being studied: Smart Water Bottle
Conditions: Dehydration
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Participants must report currently drinking less than the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (\<2.5 L per day for males; \<2.0 L per day for females).
- Has access to a cell phone which can download the app associated with the Smart Water Bottle.
Exclusion Criteria
- Currently trying to gain or lose weight
- Have had surgery of the digestive tract
- Currently taking diuretics (e.g., Thiazide, Loop diuretics or potassium-sparing diuretics)
- Currently taking centrally-acting medications (e.g., anesthetics, anticonvulsants, central nervous system stimulants/amphetamines, muscle relaxants)
- Report currently consuming at least the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (>= 2.5 L per day for males, >=2.0 L per day for females).
- Currently pregnant (females)
Recruiting US locations
Kennesaw State University
Kennesaw, GA 30144
Site contact: Mitchell Zaplatosch, PhD · mzaplato@kennesaw.edu
Study contacts (from the official record)
- Mitchell E Zaplatosch, PhD · 4705787600 · mzaplato@kennesaw.edu
Similar studies in Georgia
All diabetes studies in Georgia →- RecruitingHealthy volunteersEarly Phase 1
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Augusta University
- Location
- Augusta, GA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Atlanta, GA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Augusta, GA + 121 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Atlanta, GA + 11 other US sites
- Eligibility basics
- Ages 18–80